Abstract: A system and method for treating the surface of an optical lens is provided. A predetermined pressure and a plasma gas are maintained in a coating chamber. A plasma cloud of gas is established between electrodes in the chamber. An entry chamber is upstream from the coating chamber, and an exit chamber is disposed downstream from the chamber. A lens is moved into the entry chamber, and at least a portion of the entry chamber adjacent to the coating chamber is brought to the predetermined pressure. Process gas is introduced into this area. The entry chamber is then brought into communication with the coating chamber, and the lens is moved into the coating chamber and through the cloud. Process gas is introduced into at least a portion of the exit chamber adjacent the coating chamber, and this portion is brought to the predetermined pressure. The lens is then moved from the coating chamber to the exit chamber.

Abstract: An apparatus for low temperature plasma treatment of powder particles for modifying the surface properties thereof, comprising means for the creation of a low pressure zone and, in association therewith, at least one cascade arc torch generator to form a plasma torch which is directed into said low pressure zone, means for the supply by gravity of powder particles to be treated into said low pressure zone and conduit means for the removal of the treated powder particles from said low pressure zone, said cascade arc generator having an orientation such that said plasma torch enters said low pressure zone at a downward angle (.alpha.) to the horizontal of from about 15.degree. to about 60.degree., and said conduit means being directed away from said plasma torch at an upward angle (.beta.) to the horizontal of from about 15.degree. to about 80.degree.

Abstract: Disclosed is a method of producing implantable prosthetic devices, e.g., tubular vascular prostheses having a substantially non-thrombogenic inside surface and a biocompatible outside surface. The method involves deposition onto an elongate substrate, e.g., a porous tubular substrate, of a fluorine-containing coating by inducing glow discharge progressively along the length of a tubular reaction vessel. A polymerizable fluorine-containing gas is flowed through the tubular substrate and a portion of the gas migrates radially to traverse the pores of the substrate. An RF field is applied to successive volumes of the gas within the vessel and tube. A substantially non-thrombogenic fluorinated coating with a first fluorine to carbon ratio deposits and bonds to the inside surface of the substrate, and a fluorinated biocompatible cross-linked coating with a lower F/C atomic ratio than the inside coating deposits and bonds to the outside surface of the substrate.

Abstract: Disclosed is a method of producing implantable prosthetic devices, e.g., tubular vascular prostheses having a substantially non-thrombogenic inside surface and a biocompatible outside surface. The method involves deposition onto an elongate substrate, e.g., a porous tubular substrate, of a fluorine-containing coating by inducing glow discharge progressively along the length of a tubular reaction vessel. A polymerizable fluorine-containing gas is flowed through the tubular substrate and a portion of the gas migrates radially to traverse the pores of the substrate. An RF field is applied to successive volumes of the gas within the vessel and tube. A substantially non-thrombogenic fluorinated coating with a first fluorine to carbon ratio deposits and bonds to the inside surface of the substrate, and a fluorinated biocompatible cross-linked coating with a lower F/C atomic ratio than the inside coating deposits and bonds to the outside surface of the substrate.

Abstract: The invention presents a high-viscosity eye lotion with which lasting curve effects can be obtained with no feeling of foreign bodies to the eye as in the conventional eye salves used in treating eyes.The high-viscosity eye lotion of the invention comprises a swollen hydrated gel of a crosslinked polyvinyl alcohol and an eye-disease curative active ingredient contained therein. It is prepared by irradiating an aqueous solution of a polyvinyl alcohol with an ionizing radiation to such an extent that the polyvinyl alcohol is crosslinked to give a hydrated gel with an equilibrium swelling ratio in the range from 70 to 100 by weight and then dipping the hydrated gel in an aqueous solution of the eye-disease curative active agent.